1 month ago

UCB Announces U.S. FDA Approvals for BIMZELX ® (bimekizumab-bkzx) for the Treatment of Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis

Read Entire Article

© NewsMage 2024. All rights are reserved